Monthly Archives: July 2015

Bass Goes Fishing: Troubles Ahead for Pharma?

By Tom Engellenner Note: This article is adapted from a longer guest post on Forbes.com last week. To view the Forbes article click here. Inter partes review (IPR) is a process established by Congress to permit defendants in patent infringement … Continue reading

Posted in America Invents Act, Anticipation/Obvious, BRI Standard, Broadest Reasonable Interpretation, Claim Construction, Instittion Decision, Inter Partes Review, PTAB Procedure, Trial Tactics, Uncategorized, USPTO | Tagged , , , , , , , , ,

PTAB’s Broadest Reasonable Interpretation Rule Survives Another Challenge (Barely)

By Tom Engellenner The Court of Appeals for the Federal Circuit denied Cuozzo Speed Technology LLC’s petition for en banc rehearing of a February panel decision affirming the PTAB’s use the so-called broadest reasonable interpretation (BRI) standard in claim construction. … Continue reading

Posted in Uncategorized

Post-Grant Challenges In Life Sciences: A Midyear Assessment

By Raymond A. Miller and N. Nicole Stakleff The America Invents Act established inter partes review and post-grant reviews mechanisms to challenge the validity of issued United States patents. These procedures were created to improve patent quality, and were introduced in … Continue reading

Posted in Uncategorized